Duloxetine Hydrochloride Patent Expiration
Duloxetine Hydrochloride was first introduced by Eli Lilly And Co
Duloxetine Hydrochloride Patents
Given below is the list of patents protecting Duloxetine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Cymbalta | US5023269 | 3-aryloxy-3-substituted propanamines |
Jun 11, 2013
(Expired) | Lilly |
Cymbalta |
US5023269 (Pediatric) | 3-aryloxy-3-substituted propanamines |
Dec 11, 2013
(Expired) | Lilly |
Cymbalta | US5508276 | Duloxetine enteric pellets |
Jul 18, 2014
(Expired) | Lilly |
Cymbalta |
US5508276 (Pediatric) | Duloxetine enteric pellets |
Jan 18, 2015
(Expired) | Lilly |
Cymbalta | US6596756 | Treatment of fibromyalgia |
Sep 10, 2019
(Expired) | Lilly |
Cymbalta |
US6596756 (Pediatric) | Treatment of fibromyalgia |
Mar 10, 2020
(Expired) | Lilly |
Drizalma Sprinkle | US10413525 | Duloxetine sprinkles | Apr 13, 2037 | Sun Pharm |
Drizalma Sprinkle | US10959982 | Duloxetine sprinkles | Apr 13, 2037 | Sun Pharm |
Drizalma Sprinkle | US11202772 | Duloxetine sprinkles | Apr 13, 2037 | Sun Pharm |
Drizalma Sprinkle | US9839626 | Duloxetine sprinkles | Apr 13, 2037 | Sun Pharm |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳
Duloxetine Hydrochloride Generics
Several generic applications have been filed for Duloxetine Hydrochloride. The first generic version for Duloxetine Hydrochloride was by Teva Pharmaceuticals Usa and was approved on Dec 11, 2013. And the latest generic version is by Zydus Healthcare Usa Llc and was approved on Apr 18, 2023.
Given below is the list of companies who have filed for Duloxetine Hydrochloride generic.
1. QINGDAO BAHEAL PHARM
Qingdao Baheal Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Qingdao Baheal Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Apr 17, 2019 |
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Apr 17, 2019 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Apr 17, 2019 |
2. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 3, 2016 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 3, 2016 |
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 3, 2016 |
3. MARKSANS PHARMA
Marksans Pharma Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Marksans Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Dec 11, 2013 |
EQ 30MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Dec 11, 2013 |
EQ 60MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Dec 11, 2013 |
4. SUNSHINE
Sunshine Lake Pharma Co Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sunshine.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Feb 11, 2021 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Feb 11, 2021 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Feb 11, 2021 |
5. APOTEX
Apotex Inc has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Jun 11, 2014 |
EQ 30MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Jun 11, 2014 |
EQ 60MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Jun 11, 2014 |
6. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jun 9, 2014 |
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jun 9, 2014 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jun 9, 2014 |
7. TORRENT
Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
8. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 60MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Dec 11, 2013 |
EQ 30MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Dec 11, 2013 |
EQ 20MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Dec 11, 2013 |
9. LUPIN LTD
Lupin Ltd has filed for 4 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
10. ZYDUS HLTHCARE
Zydus Healthcare Usa Llc has filed for 4 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 8, 2014 |
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 8, 2014 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 8, 2014 |
EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Apr 18, 2023 |
11. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 8, 2014 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 8, 2014 |
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 8, 2014 |
12. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 17, 2013 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 17, 2013 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 17, 2013 |
13. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 6, 2017 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 6, 2017 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 6, 2017 |
EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 11, 2019 |
14. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Prinston Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | May 18, 2017 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | May 18, 2017 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | May 18, 2017 |
15. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 23, 2017 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 23, 2017 |
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 23, 2017 |
16. CSPC OUYI
Cspc Ouyi Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Cspc Ouyi.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 16, 2018 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 16, 2018 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 16, 2018 |
17. INVENTIA
Inventia Healthcare Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Inventia.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 28, 2015 |
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 28, 2015 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 28, 2015 |
18. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
19. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 11, 2013 |
20. BRECKENRIDGE
Breckenridge Pharmaceutical Inc has filed for 4 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Breckenridge.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jun 11, 2014 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jun 11, 2014 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jun 11, 2014 |
EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | May 18, 2018 |
21. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 26, 2015 |
EQ 60MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 26, 2015 |
EQ 30MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 26, 2015 |
22. ENDO OPERATIONS
Endo Operations Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 28, 2015 |
EQ 30MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 28, 2015 |
EQ 60MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 28, 2015 |
23. YAOPHARMA CO LTD
Yaopharma Co Ltd has filed for 3 different strengths of generic version for Duloxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Yaopharma Co Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 60MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Aug 16, 2019 |
EQ 20MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Aug 16, 2019 |
EQ 30MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Aug 16, 2019 |